Aromatase inhibiting drugs such as letrozole and anastrozole are established therapies for breast cancer and these drugs are currently undergoing a clinical trial as a possible therapy for endometriosis, with some encouraging results [60,61]. Here, CYP19A1 is linked to breast carcinoma.